LATITUDE 66 LIMITED — Capital/Financing Update 2016

Apr 3, 2016

==> picture [596 x 132] intentionally omitted <==

Assets, Experience, Growth

ASX ANNOUNCEMENT – 4 April 2016

ISSUE OF SHORTFALL SHARES

Syndicated Metals Limited (ASX: SMD) ( Company) is pleased to announce that it has issued 15,200,000 shares in the capital of the Company ( Shares ) at 0.5 cents per Share raising $76,000 and 7,600,000 free attaching unlisted options with each option having an exercise price of 1.2 cents and expiring on 8 February 2018 ( Options ).

The Shares were issued under the shortfall offer made pursuant to the Company’s Prospectus dated 10 December 2015 and formed part of the shortfall from the Company’s recently completed 1‐for‐6 entitlement issue. The Shares and Options were issued under the same terms and pricing as the entitlement issue.

A further $25,000 was received from an entity associated with the Company’s Chairman, Mr Peter Langworthy. Shareholder approval will be required to issue the Shares and Options associated with this application and this will be sought at the next meeting of the Company’s shareholders.

Funds raised from the issue of the new Shares will be used for the purposes set out in the Prospectus dated 10 December 2015.

An Appendix 3B is attached in relation to the above Share and Option issue.

ENDS

For further information: Andrew Munckton Syndicated Metals Limited Mobile: 0435 635 598

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

SYNDICATED METALS LIMITED

ABN

61 115 768 986

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued or to be issued 2 Number of +securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)	1. Fully paid ordinary shares (Shares). 2. Unlisted options each to acquire one Share exercisable at 1.2 cents each expiring on 8 February2018(Options).
	1. 15,200,000 Shares issued under the shortfall offer made pursuant to the Company’s Prospectus dated 10 December 2015. 2. 7,600,000 Options made pursuant to the Company’s Prospectus dated 10 December 2015 on the basis of one (1) free attaching Option for everytwo(2)Shares issued.
	1. The Shares are fully paid ordinary shares in the capital of the Company ranking equally with existing fully paid ordinary shares on issue. 2. The Options are unquoted options, each to acquire one Share, exercisable at 1.2 cents on or before 8 February 2018.

• See chapter 19 for defined terms.

Appendix 3B Page 1

04/03/2013

Appendix 3B New issue announcement

4 Do the+securities rank equally in all respects from the+issue date with an existing+class of quoted+securities? If the additional+securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i	1. Yes. 2. Shares issued on exercise of the Options will rank equally with existing fully paid ordinary shares on issue.
	1. 0.5 cents per Share. 2. Nil. The Options are free attaching Options for which no additional consideration is payable.
	Funds raised from the issue of the Shares and exercise of the Options will be used as follows:  assessment of new gold and base metals project opportunities outside of the existing North‐West Queensland tenement holding;  exploration and asset maintenance activities associated with the Company’s Queensland copper‐gold projects to ensure the tenement holding is kept in good standing;  finalisation of mining lease approvals for the Barbara Joint Venture in association with CopperChem Limited;  general working capital and administrative expenses; and  the expenses of the issue.
	Yes.

• See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

Appendix 3B New issue announcement

6b The date the security holder resolution under rule 7.1A was passed 6c Number of+securities issued without security holder approval under rule 7.1 6d Number of+securities issued with security holder approval under rule 7.1A 6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of+securities issued under an exception in rule 7.2 6g If+securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. 6h If+securities were issued under rule 7.1A for non‐cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B.	26 November 2015
	1. 15,200,000 Shares. 2. 7,600,000 Options.
	Nil.
	Nil.
	1. 15,200,000 Shares. 2. 7,600,000 Options.
	N/A
	N/A
	Refer Annexure 1.
	4 April 2016

• See chapter 19 for defined terms.

Appendix 3B Page 3

04/03/2013

Appendix 3B New issue announcement

8 Number and +class of all +securities quoted on ASX (_including_the +securities in section 2 if applicable) 9 Number and +class of all +securities not quoted on ASX (_including_the +securities in section 2 if applicable) 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)	Number	+Class
	479,442,464	Ordinary shares
	Number	+Class
	2,252,250 2,252,250 2,252,257 5,000,000 2,500,000 4,750,000 4,750,000 250,000 250,000 250,000 150,000 150,000 150,000 2,452,473 3,471,231 52,599,182	16.4c options expiry 29/5/16 20.5c options expiry 29/5/16 24.6c options expiry 29/5/16 6.4c options expiry 9/1/17 Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.30. Expire 29/5/2016. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.45. Expire 29/5/2016. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.60. Expire 29/5/2016. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.30. Expire 8/11/2016. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.45. Expire 8/11/2016. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.60. Expire 8/11/2016. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.30. Expire 19/2/2017. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.45. Expire 19/2/2017. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.60. Expire 19/2/2017. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.06675. Expire 21/10/2018. Performance Rights vesting when the Company’s 10 day VWAP exceeds $0.11125. Expire 21/10/2018. 1.2c options expiry8/2/18
	N/A

• See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Appendix 3B New issue announcement

Part 2 - Pro rata issue

• 11 Is security holder approval required?

• 12 Is the issue renounceable or non‐ renounceable?

• 13 Ratio in which the[+] securities will be offered

• 14 +Class of +securities to which the offer relates

15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions

18 Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7.

19 Closing date for receipt of acceptances or renunciations

• See chapter 19 for defined terms.

Appendix 3B Page 5

04/03/2013

Appendix 3B New issue announcement

20	Names of any underwriters
21	Amount of any underwriting fee
	or commission
22	Names of any brokers to the
	issue
23	Fee or commission payable to
	the broker to the issue
24	Amount of any handling fee
	payable to brokers who lodge
	acceptances or renunciations on
	behalf of security holders
25	If the issue is contingent on
	security holders’ approval, the
	date of the meeting
26	Date entitlement and acceptance
	form and offer documents will be
	sent to persons entitled
27	If the entity has issued options,
	and the terms entitle option
	holders to participate on
	exercise, the date on which
	notices will be sent to option
	holders
28	Date rights trading will begin (if
	applicable)
29	Date rights trading will end (if
	applicable)
30	How do security holders sell
	their entitlements_in full_through
	a broker?
31	How do security holders sell_part_
	of their entitlements through a
	broker and accept for the
	balance?

• See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Appendix 3B New issue announcement

• 32 How do security holders dispose of their entitlements (except by sale through a broker)?

• 33 +Issue date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of[+] securities ( tick one )

• (a)  +Securities described in Part 1 ( Shares Only )

• (b) All other[+] securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

• 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

• 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 ‐ 1,000 1,001 ‐ 5,000 5,001 ‐ 10,000 10,001 ‐ 100,000 100,001 and over

• 37 A copy of any trust deed for the additional[+] securities

• See chapter 19 for defined terms.

Appendix 3B Page 7

04/03/2013

Appendix 3B New issue announcement

Entities that have ticked box 34(b)

38 Number of+securities for which +quotation is sought 39 +Class of+securities for which quotation is sought 40 Do the+securities rank equally in all respects from the+issue date with an existing+class of quoted +securities? If the additional+securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another+security, clearly identify that other+security) 42 Number and +class of all +securities quoted on ASX (including the +securities in clause 38)
	Number	+Class

• See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Appendix 3B New issue announcement

Quotation agreement

• 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

• 2 We warrant the following to ASX.

• The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

• There is no reason why those[+] securities should not be granted +quotation.

• An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no‐one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

• If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [115 x 41] intentionally omitted <==

Sign here: ............................................................ Date: 4 April 2016

Company Secretary

Print name: Paul Bridson

== == == == ==

• See chapter 19 for defined terms.

Appendix 3B Page 9

04/03/2013

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [415 x 452] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid [+] ordinary 274,445,673
securities on issue 12 months before the
+ issue date or date of agreement to issue
Add the following:
• Number of fully paid [+] ordinary securities 99,798,427 (20 April 2015)
issued in that 12 month period under an
exception in rule 7.2 32,118,364 (8 February 2016)
15,200,000 (4 April 2016)
• Number of fully paid [+] ordinary securities 26,000,000 (8 December 2015)
issued in that 12 month period with
shareholder approval 31,880,000 (8 February 2016)
• Number of partly paid [+] ordinary
securities that became fully paid in that
12 month period
Note: 0
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid [+] ordinary 0
securities cancelled during that 12 month
period
“A” 479,442,464
----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”

“B” 0.15 [Note: this value cannot be changed] Multiply “A” by 0.15 71,916,369

Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used

==> picture [415 x 374] intentionally omitted <==

----- Start of picture text -----

Insert number of [+] equity securities issued 0
or agreed to be issued in that 12 month
period not counting those issued:
• Under an exception in rule 7.2 0
• Under rule 7.1A 0
• With security holder approval under rule 0
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
“C” 0
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15 71,916,369
Note: number must be same as shown in
Step 2
----- End of picture text -----

placement capacity under rule 7.1
“A” x 0.15	71,916,369
Note: number must be same as shown in
Step 2
Subtract“C”	0
Note: number must be same as shown in
Step 3
Total[“A” x 0.15] – “C”	71,916,369
	[Note: this is the remaining placement
	capacity under rule 7.1]

• See chapter 19 for defined terms.

Appendix 3B Page 11

04/03/2013

Appendix 3B New issue announcement

Part 2

Rule 7.1A – Additional placement capacity for eligible entities Step 1: Calculate “A”, the base figure from which the placement capacity is calculated “A” 479,442,464 Note: number must be same as shown in Step 1 of Part 1 Step 2: Calculate 10% of “A” “D” 0.10 Note: this value cannot be changed Multiply “A” by 0.10 47,944,246 Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used Insert number of[+] equity securities issued 0 or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items “E” 0

• See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Appendix 3B New issue announcement	Appendix 3B New issue announcement
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
“A” x 0.10 Note: number must be same as shown in Step 2	47,944,246
Subtract“E” Note: number must be same as shown in Step 3	0
Total[“A” x 0.10] – “E”	47,944,246 Note: this is the remaining placement capacity under rule 7.1A

• See chapter 19 for defined terms.

Appendix 3B Page 13

04/03/2013